CA2+-MEDIATED MECHANISMS OF ATRIAL PACEMAKER ACTIVITY

CA2 介导的心房起搏器活动机制

基本信息

  • 批准号:
    6390554
  • 负责人:
  • 金额:
    $ 29.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-07-01 至 2005-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (adapted from the applicant's description): The long-range goal of the applicant is to understand the physiological mechanisms that determine and regulate atrial pacemaker activity, particularly with respect to latent atrial pacemakers and their contribution to atrial dysfunction. Latent atrial pacemakers are specialized cells localized in specific regions of the right atrium outside of the SA node region. They are thought to participate in a wide variety of atrial arrhythmias including brady-tachy syndrome, atrial tachycardia, supraventricular tachycardia and atrial fibrillation. Although of major clinical importance, the cellular mechanisms underlying latent atrial pacemaker activity are not well understood. Preliminary results by the applicant indicate that latent atrial pacemaker activity is regulated by bursting of local intracellular Ca2+ release, i.e., Ca2+ sparks, from the sarcoplasmic reticulum (SR) specifically during the late phase of diastolic depolarization. The mechanisms governing diastolic release of SR Ca2+ in atrial pacemaker cells is not clear. Whole-cell (perforated & ruptured patch) recording methods and measurements of intracellular Ca2+ concentration ((Ca)i) using laser scanning confocal microscopy will be used to determine the mechanism governing diastolic SR Ca2+ release in latent atrial and SA node pacemaker cells isolated from cat right atrium. The following hypotheses will be tested: 1) voltage-dependent activation of T-type Ca2+ current (ICa,T) during the late diastolic slope triggers SR Ca2+ release which in turn stimulates inward Na/Ca exchange current to depolarize the membrane to threshold, 2) both acetylcholine and norepinephrine regulate diastolic SR Ca2+ release triggered by ICa,T and thereby regulate atrial pacemaker activity, 3) by elevating (Ca)i, cardiac glycosides and low extracellular (K) enhance this normal mechanism of atrial pacemaker automaticity, and thereby elicit atrial dysrhythmias not dependent on Ca2+ overload of the SR, 4) low temperature inhibits atrial pacemaker activity by inhibiting diastolic SR Ca2+ release triggered by ICa,T, and 4) transitional atrial pacemaker cells lack diastolic time-dependent currents and therefore depend primarily on SR Ca2+ release triggered by ICa,T for their pacemaker mechanism. It is expected that the results gained from these studies will provide fundamental insight into the cellular mechanisms governing normal and abnormal atrial pacemaker function.
描述(改编自申请人的描述):的长期目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN Lloyd LIPSIUS其他文献

STEPHEN Lloyd LIPSIUS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN Lloyd LIPSIUS', 18)}}的其他基金

Beta-Adrenergic Receptor Function in Atrial Myocytes
心房肌细胞中的β-肾上腺素能受体功能
  • 批准号:
    6985298
  • 财政年份:
    2005
  • 资助金额:
    $ 29.79万
  • 项目类别:
Beta-Adrenergic Receptor Function in Atrial Myocytes
心房肌细胞中的β-肾上腺素能受体功能
  • 批准号:
    7077777
  • 财政年份:
    2005
  • 资助金额:
    $ 29.79万
  • 项目类别:
Beta-Adrenergic Receptor Function in Atrial Myocytes
心房肌细胞中的β-肾上腺素能受体功能
  • 批准号:
    7437291
  • 财政年份:
    2005
  • 资助金额:
    $ 29.79万
  • 项目类别:
Beta-Adrenergic Receptor Function in Atrial Myocytes
心房肌细胞中的β-肾上腺素能受体功能
  • 批准号:
    7237247
  • 财政年份:
    2005
  • 资助金额:
    $ 29.79万
  • 项目类别:
CA2+-MEDIATED MECHANISMS OF ATRIAL PACEMAKER ACTIVITY
CA2 介导的心房起搏器活动机制
  • 批准号:
    6762379
  • 财政年份:
    2000
  • 资助金额:
    $ 29.79万
  • 项目类别:
CA2+-MEDIATED MECHANISMS OF ATRIAL PACEMAKER ACTIVITY
CA2 介导的心房起搏器活动机制
  • 批准号:
    6604665
  • 财政年份:
    2000
  • 资助金额:
    $ 29.79万
  • 项目类别:
CA2+-MEDIATED MECHANISMS OF ATRIAL PACEMAKER ACTIVITY
CA2 介导的心房起搏器活动机制
  • 批准号:
    6537705
  • 财政年份:
    2000
  • 资助金额:
    $ 29.79万
  • 项目类别:
CA2+-MEDIATED MECHANISMS OF ATRIAL PACEMAKER ACTIVITY
CA2 介导的心房起搏器活动机制
  • 批准号:
    6027987
  • 财政年份:
    2000
  • 资助金额:
    $ 29.79万
  • 项目类别:
ELECTROPHYSIOLOGY OF RIGHT ARTIAL SUBSIDIARY PACEMAKERS
右侧辅助起搏器的电生理学
  • 批准号:
    2216166
  • 财政年份:
    1982
  • 资助金额:
    $ 29.79万
  • 项目类别:
ELECTROPHYSIOLOGY OF RIGHT ATRIAL SUBSIDIARY PACEMAKERS
右心房附属起搏器的电生理学
  • 批准号:
    3339256
  • 财政年份:
    1982
  • 资助金额:
    $ 29.79万
  • 项目类别:

相似海外基金

L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
  • 批准号:
    10668210
  • 财政年份:
    2023
  • 资助金额:
    $ 29.79万
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
  • 批准号:
    10603554
  • 财政年份:
    2023
  • 资助金额:
    $ 29.79万
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
  • 批准号:
    10684558
  • 财政年份:
    2023
  • 资助金额:
    $ 29.79万
  • 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
  • 批准号:
    10815882
  • 财政年份:
    2023
  • 资助金额:
    $ 29.79万
  • 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
  • 批准号:
    10628914
  • 财政年份:
    2023
  • 资助金额:
    $ 29.79万
  • 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
  • 批准号:
    10734121
  • 财政年份:
    2023
  • 资助金额:
    $ 29.79万
  • 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
  • 批准号:
    10628911
  • 财政年份:
    2023
  • 资助金额:
    $ 29.79万
  • 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
  • 批准号:
    2200474
  • 财政年份:
    2022
  • 资助金额:
    $ 29.79万
  • 项目类别:
    Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
  • 批准号:
    452107
  • 财政年份:
    2021
  • 资助金额:
    $ 29.79万
  • 项目类别:
    Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
  • 批准号:
    10399417
  • 财政年份:
    2021
  • 资助金额:
    $ 29.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了